28.1 C
Vientiane
Friday, July 11, 2025
spot_img
Home Blog Page 283

SK bioscience Joins Korea’s National Initiative to Develop Avian Influenza Vaccine Amid Rising Pandemic Threats

  • Company aims to develop a bird flu vaccine with rapid mass production and variant responsiveness.
  • SK bioscience and KDCA join forces to build a national pandemic preparedness and response system for potential next-pandemic avian influenza.
  • “We will promote global public health and grow as a global leader, building on our COVID-19 response experience.”

SEONGNAM, South Korea, May 6, 2025 /PRNewswire/ — SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, today announced that it has been selected for the Korea Disease Control and Prevention Agency (KDCA)’s Priority Infectious Disease Pandemic Preparedness Rapid R&D Support Program.

Researchers at SK bioscience are analyzing the vaccine candidate.
Researchers at SK bioscience are analyzing the vaccine candidate.

This government-led initiative aims to develop vaccines against avian influenza – identified as a high-risk candidate for the next pandemic. SK bioscience was chosen for its proven technological capabilities as the only domestic company to have commercialized cell-culture-based vaccines for both influenza and COVID-19.

Under the program, SK bioscience and KDCA will co-invest approximately KRW 5.25 billion (USD 3.7 million) in early-stage development. The company will initiate development of a cell-culture-based avian influenza vaccine, aiming to enter Phase 1/2 clinical trials in the second half of next year. Furthermore, the company plans to foster international collaboration alongside its vaccine development to enhance global public health as the threat of avian influenza is not confined to a single region or country.

Unlike traditional egg-based vaccines, cell-culture-based vaccines offer greater effectiveness in pandemic response. Egg-based vaccines can face significant challenges during avian influenza outbreaks, as mass culling of poultry may limit access to uninfected fertilized eggs, making timely and large-scale vaccine production difficult and less responsive to emerging viral mutations.

In contrast, cell-culture-based vaccines are produced using animal cells in advanced aseptic facilities, minimizing the risk of contamination or infection. This method enables rapid, large-scale manufacturing and allows for quicker adaptation to evolving virus strains.

SK bioscience has already utilized its cell-culture platform to develop vaccines against a range of viral diseases. During the COVID-19 pandemic, the company played a pivotal role by manufacturing vaccines for global partners and successfully launching its own COVID-19 vaccine. These achievements highlight the company’s strong capabilities in both development and production, reinforcing its preparedness for future pandemic.

While human-to-human transmission of avian influenza remains low, highly pathogenic strains such as H5N1 and H7N9 continue to pose serious global threats. According to the World Health Organization (WHO), more than 950 human cases of avian influenza infection have been reported worldwide between 1997 and January 2025, with approximately half resulting in death. Experts warn that if H5N1 mutates to enable human-to-human transmission, it could trigger a deadly pandemic.

SK bioscience is also developing mRNA vaccines as part of its pandemic preparedness strategy. The mRNA technology, which demonstrated effectiveness during the COVID-19 pandemic, is well-suited for responding to highly transmissible diseases thanks to its rapid development timeline and scalability for mass production.

The company is currently conducting global Phase 1/2 clinical trials of its mRNA Japanese encephalitis vaccine candidate, GBP560, in collaboration with the Coalition for Epidemic Preparedness Innovations (CEPI). Interim results are expected next year.

Jaeyong Ahn, CEO of SK bioscience, said, “Our partnership with the Korean government and global organizations in pandemic response underscores our world-class technological and production capabilities. We are committed to strengthen our readiness for the next pandemic and fulfilling our mission to promote global health, laying the foundation to become a global vaccine and biotech leader.”

About SK bioscience

SK bioscience is an innovative vaccine and biotech company, committed to vaccine development and manufacturing to enable more equitable access to vaccines around the world. Leveraging strengths on cutting-edge technologies, SK bioscience has been dedicated to promoting human health from prevention to cure across the globe. With the cooperation of domestic and international governments, regulatory agencies, healthcare providers, doctors, and medical experts, all of the SK colleagues are passionately committed to providing high-quality vaccines to those who need them and better public healthcare solutions.

SK bioscience Website
– SK bioscience Linkedin

Contact
SK bioscience Communications Team
Changhyun Jin (jin99@sk.com
Jeannie S. Pak (j.pak@sk.com)

FIC Global Expands Optical Transceiver Business to Enable Innovation at the Speed of Light

TAIPEI, May 6, 2025 /PRNewswire/ — FIC Global Inc. (TWSE: 3701; FICG), a leading expert in packaging and installing semiconductors on optical modules for 16 years, today announced a significant expansion of its optical transceiver business to meet the rapidly evolving demands of silicon photonics optical transceivers for next-generation data center networking.

FICG expands its optical transceiver business to meet the rising demand of next-gen networking.
FICG expands its optical transceiver business to meet the rising demand of next-gen networking.

For information on FICG’s latest earnings and business updates, please visit: https://www.ficg.com.tw/en/financials-monthly-reports/

Empowering the 1.6T era

As AI-powered data centers scale in complexity and density, co-packaged optics (CPO) switches — highlighted recently at GTC 2025 — have emerged as a solution for ultra-fast intercommunication, reduced energy consumption, and minimal latency, with the new benchmark for data transmission speeds now 1.6 terabits (T) per second. Optical transceivers — key components that convert electrical signals into light data for transmission over fiber optic cables — are driving this transformation.

“Our expansion reinforces FICG’s role at the heart of the optical transceiver revolution,” commented Mr. Leo Chien, Chairman of FICG. “Powered by FICG’s cutting-edge manufacturing technology, competitive yields, and comprehensive capabilities, we are innovating at the speed of light to enable 1.6T and 3.2T.”

As part of the expansion, the company will announce new manufacturing facilities later this year.

A legacy of expertise, innovation, and collaboration

FICG’s leadership is built on a legacy of expertise in joint design manufacturing (JDM) for optical modules. Working closely with semiconductor makers upstream and optical transceiver customers downstream, the company leverages advanced techniques to package electronic and optical semiconductors and install them onto the core printed circuit boards (PCBs) of optical modules.

With experience in optical transceivers since 2008, these now represent over 50% of FICG’s revenue, and the company continues to grow:

  • Market leadership: In 2024, FICG achieved 17.5% market share in 800G and 1.6T optical transceivers and 20% market share in 400G optical transceivers.
  • A key ecosystem player: FICG supplies major players worldwide and collaborates closely with chip manufacturers in Taiwan.
  • Significant growth: To meet major sales growth recently, the company has tripled optical module production capacity over the past two years.
  • Future-forward innovation: FICG is actively innovating to prepare for transmission speeds to double from 1.6T to 3.2T.

Standing out through process leadership

As the backbone of silicon photonics, FICG maintains process leadership through advanced R&D capabilities, a unique combination of capabilities, and innovation in manufacturing technology. The company particularly stands out for its ability to integrate higher-tech manufacturing processes like 2.5D and 3D semiconductor packaging and bare-die flip chip installation with the more mainstream surface mount technology for the rest of a PCBA, enabling customers to consolidate and simplify their supply chains.

FICG is also recognized by global customers for precision and yield quality:

  • Ultra-high first-pass yield rates: For exceptional reliability
  • Ultra-fine component installation: Capable of installing component sizes such as 008004 (0.25×0.125 mm), 01005 (0.4×0.2 mm), and 0201 (0.6×0.3 mm) — almost as small as a hair’s breadth
  • Rigorous quality control: Leveraging 3D X-ray and soldering testing for uncompromising standards

FICG’s excellence has earned it recognition from one customer as its leading optical transceiver brand supplier for three consecutive years, along with achievements such as CMMI Level 3 Maturity Certification and ranking 23rd worldwide in the MMI Top 50™ EMS Providers in 2024.

About FIC Global Inc.
FIC Global Inc. (TWSE: 3701) is a leading provider of optical transceivers, specializing in the semiconductor packaging and advanced printed circuit board (PCB) assembly.  Formed by the integration of FIC, Ubiqconn and 3cems, FICG leverages a strong foundation of expertise to deliver innovative solutions. With expertise in optical modules since 2008, FICG has rapidly grown into a key player in the global supply chain, collaborating with major industry leaders worldwide and standing out for cutting-edge, high-yield manufacturing capabilities.

https://www.ficg.com.tw/en/

Canton Fair: Smart Home Revolution Takes Center Stage

GUANGZHOU, China, May 6, 2025 /PRNewswire/ — “You’ll see a mix of modern international design trends, making it a goldmine for buyers who want unique globally inspired home goods.” said Venezuelan influencer Rafa, who perfectly captured the innovative spirit of this year’s Canton Fair as he was experiencing and filming the event.

Rafa’s tour of the Canton Fair revealed how smart technology is reshaping the modern lifestyle. Visitors were impressed by high-tech toilets featuring motion-activated lids, adjustable water and seat temperatures, and even built-in Bluetooth speakers for personalized entertainment. The exhibition also showcased luxurious multi-functional massage bathtubs that make ordinary bathrooms premium spa retreats, offering hydrotherapy jets and mood lighting.

The innovation extended beyond product displays to its services. Covering 1.5 million square meters across four sections (Areas A-D) with approximately 35,000 exhibitors, the venue implemented an advanced navigation system featuring robotic arm kiosks with interactive screens. These intelligent wayfinding stations generate optimal routes while physical indicators point toward selected destinations, along with precise distance measurements to guide attendees efficiently through the massive complex.

For those who are interested in the future of smart home and witnessing the Canton Fair’s impressive innovations firsthand, Rafa’s video offers a closer look at these groundbreaking developments in the global home furnishing industry.

Want to learn more about smart homes and the Canton Fair’s intelligent exhibition guide? Click the video link below and follow Rafa’s lens to explore the new trends in the sector.

YouTube Link:https://www.youtube.com/watch?v=HieC4VV7ZEk

Niall Prendiville Joins CSafe as Chief Product Officer to Drive Continued Growth in Innovation Across the Product Portfolio

Prendiville brings over 25 years of expertise in product, engineering, automation and supply chain operations

MONROE, Ohio, May 6, 2025 /PRNewswire/ — CSafe, a leading active and passive temperature-controlled shipping solutions provider for the life sciences industry, announced today that Niall Prendiville has joined its team as the Chief Product Officer. 

Niall is a global product and engineering leader with deep expertise in engineering, automation, and supply chain operations. He has successfully led product development, engineering, and business transformations across high-tech industries, including warehouse automation, power systems, and aerospace. As the Chief Product Officer at CSafe, he will drive innovation, product strategy, and commercialization to support the company’s long-term success across CSafe’s robust portfolio of active and passive temperature-controlled shipping solutions for life sciences, cell and gene therapy, military applications and more.

Throughout his career, Niall has focused on lean management, product development, and the commercialization of innovative solutions. He has a strong track record of bringing products to the market, optimizing development processes, and aligning technology with business objectives. His expertise in cost management, scaling operations, and driving profitability has helped organizations enhance their product offerings and market impact.

Based in Monroe, OH at CSafe’s corporate office, Prendiville will be positioned to lead CSafe’s global product roadmap and support the company’s mission to ensure patients around the world receive the medicines and treatments they need.

“Niall brings a wealth of experience in product strategy and engineering. As we continue as a market leader with our global portfolio of solutions, we will further accelerate our product development, continually focusing on meeting our customers’ needs and delivering meaningful value,” said Patrick Schafer, CEO. “We’re pleased to welcome Niall to our team, where his skills will help to bring our future product vision to life.”

Media Contact:

Lauren LaVelle

Sr. Marketing Manager

Direct: +1 513 713 1913

Email: llavelle@csafeglobal.com

Web: csafeglobal.com

About CSafe

CSafe has been committed to ensuring life-enhancing therapies reach patients around the globe since 1979. With a patient-first approach, deep industry expertise, and focus on innovation, backed by an unparalleled service offering, CSafe provides peace of mind through best-in-class temperature-controlled solutions for the delivery of life-enhancing products. CSafe offers a comprehensive portfolio of active and passive bulk air cargo, parcel, cell and gene, specialty and advanced digital solutions. – Temperature Assured. Life Enhanced. csafeglobal.com

Niall Prendiville, CSafe
Niall Prendiville, CSafe

 

“Gedeon Richter House of Hope” opens its doors to support 300 women annually in Africa-Bamako

BUDAPEST, Hungary, May 6, 2025 /PRNewswire/ — A center providing healthcare and educational support as well as shelter for vulnerable women has been built in Bamako, the capital of Mali, with financial assistance from Gedeon Richter. As one of the world’s leading manufacturers of women’s healthcare medications, Richter emphasizes the importance of promoting women’s health and quality of life in every country where it operates. With the new center, capable of sheltering dozens of underprivileged women of the region Richter aims to provide help for nearly 300 women annually. This initiative is not just a one-time investment as the pharmaceutical company is committed to the long-term support of the operation of the House of Hope center.

Andrea Morris (House of Hope) and Mme Assetou Touré, Operations manager
Andrea Morris (House of Hope) and Mme Assetou Touré, Operations manager

The foundation stone of the Gedeon Richter House of Hope in Bamako was laid in early February 2024, with the aim of giving hope for women escaping violence for a more fulfilling life by providing them proper gynecological care and education. The center has been operational since the beginning of 2025. Besides medical and educational support, House of Hope also provides psychological and legal help and offering job opportunities at the center.

The “Gedeon Richter House of Hope” was implemented by the Hungary-based Close to Africa Foundation in cooperation with its local partner, the Sini Sanuman Foundation. Richter covered a substantial portion of the construction costs and will also support the operation for at least the next 4 years. Part of the equipment expenses were covered by the Hungary Helps Program, an initiative of the Hungarian Government. The center was designed by a team of Hungarian architects who also ensured that the building is appropriately constructed for the African conditions. The Hungarian NGO also received donations from numerous private individuals as well, and they are still looking for donations to further expand the functions of House of Hope.

Richter, as a responsible European company headquartered in Hungary, has long sought opportunities to support regions beyond our traditional markets, this time focusing on the developing World. We will provide support for women in need with the same dedication and passion in Africa as we have successfully done for decades in many of our markets. Our company supports and organizes numerous health and educational initiatives in line with our mission to promote health and improve people’s quality of life. Women’s health initiatives have always been a core focus for us” – said Zsuzsa Beke, Head of PR and Public Affairs at Gedeon Richter.

The president of the Close to Africa foundation, Andrea Morris added: “We are grateful to Gedeon Richter and the Hungary Helps Program for their generous donations. In today’s challenging economic climate, securing donors, particularly for such a unique project, is increasingly difficult. I am confident that our local knowledge, experience and dedication will help us to give support to approximately 300 women annually, providing them a second chance. I truly believe we are making a meaningful difference.

About Gedeon Richter Plc.

Richter aspires to be a global innovator in some key scientific fields, while dedicated to making medicines more accessible worldwide. Founded in 1901, headquartered in Hungary, with a market capitalization of EUR 4.7bn and sales of EUR 2.2bn in 2024, it operates Central Europe’s largest R&D hub. Its research drives breakthroughs in Neuropsychiatry and Women’s Healthcare, while Biotechnology and General Medicines strengthen its affordable treatment portfolio. Committed to sustainable growth, Richter invests in R&D, manufacturing excellence, and digitalization to advance medical innovation. Learn more at www.gedeonrichter.com

Local participants at House of Hope opening
Local participants at House of Hope opening

 

Gedeon Richter House of Hope building
Gedeon Richter House of Hope building

 

 

Iridium Equips 9603 Module with Enhanced Short Burst Data Capabilities for Government Users

MCLEAN, Va., May 6, 2025 /PRNewswire/ — Iridium Communications Inc. (Nasdaq: IRDM), a leading provider of global voice and data satellite communications, today announced a special U.S. government version of the Iridium® 9603 module built for Enhanced Short Burst Data (ESBD). ESBD is a low-latency and secure messaging service designed to provide optimal transmission security (TRANSEC) for the U.S. government and approved allies.

Iridium Satellite Network
Iridium Satellite Network

The ESBD version can act as a drop-in replacement for the existing Iridium 9603 Short Burst Data® (SBD®) module. Alongside Iridium’s known reliability and resiliency, Iridium 9603 ESBD can deliver secure one- or two-way messaging with an increased payload capacity for mobile-originated (MO) and mobile-terminated (MT) messages. Example applications range from command and control (C2) and image data transfer to personnel and asset tracking.

“Iridium 9603 ESBD is a testament to Iridium’s commitment to investing in secure, low-latency solutions that address threats in the changing global environment,” said Scott Scheimreif, executive vice president, government programs, Iridium. “The new module offers end-to-end communication security for critical operations, helping ensure warfighters can exchange vital information with confidence — no matter the environment. This capability not only safeguards mission success but also reflects the Department of Defense’s trust in Iridium’s proven technology, network reliability, and operational excellence.”

The upgraded module represents the latest innovation of Iridium to support the Enhanced Mobile Satellite Services (EMSS) program, a decades-long partnership that delivers truly global standard and secure voice, broadcast, PTT, and other services to an unlimited number of Department of Defense and DoD-approved subscribers anywhere on Earth. Iridium 9603 ESBD is targeted to be made available to EMSS-approved value-added manufacturers in July.

With its unique low-Earth orbit (LEO) satellite network, Iridium provides resilient L-band connectivity and unparalleled global coverage that does not encounter permanent line-of-sight blockages faced by geostationary (GEO) systems. This helps to ensure the delivery of mission-critical communications for the DoD and other federal agencies. Whether in high-risk combat zones or during inclement weather events, the Iridium network provides pole-to-pole satellite communications that keep users connected when it’s needed most, making it critically important for the Joint All Domain Command and Control’s (JADC2) Primary, Alternate, Contingency, and Emergency (PACE) communications architecture. 

About Iridium Communications Inc.
Iridium® is the only mobile voice and data satellite communications network that spans the entire globe. Iridium enables connections between people, organizations, and assets to and from anywhere, in real time. Together with its ecosystem of partner companies, Iridium delivers an innovative and rich portfolio of reliable solutions for markets that require truly global communications. In 2024, Iridium acquired Satelles and announced the Iridium Satellite Time and Location® service. Iridium Communications Inc. is headquartered in McLean, Va., U.S.A., and its common stock trades on the Nasdaq Global Select Market under the ticker symbol IRDM. For more information about Iridium products, services, and partner solutions, visit www.iridium.com.

Press Contact:                     

Investor Contact:

Jordan Hassin                     

Kenneth Levy

Iridium Communications Inc. 

Iridium Communications Inc.

Jordan.Hassin@Iridium.com   

Ken.Levy@Iridium.com

+1 (703) 287-7421                 

+1 (703) 287-7570

X: @Iridiumcomm               

 

 

Global Survey from World Lupus Federation Finds Nearly Half of People with Lupus Report Kidney Involvement

New data highlights urgent need for improved education and diagnosis of lupus nephritis (lupus-related kidney disease), a serious complication of lupus

WASHINGTON, May 6, 2025 /PRNewswire/ — A global survey conducted by the World Lupus Federation reveals that 47% of people living with lupus report kidney involvement, which leads to a critical and under-recognized complication known as lupus nephritis (lupus-related kidney disease). More than 43% of respondents reported having little or no knowledge about lupus nephritis, however, 85% of respondents also reported experiencing one or more symptoms associated with lupus nephritis. The survey findings underscore significant gaps in the understanding, diagnosis, and treatment of lupus nephritis, a potentially life-threatening condition that disproportionately affects people during their most active years of life.

World_Lupus_Federation_Logo_v2
World_Lupus_Federation_Logo_v2

Lupus nephritis occurs when the immune system mistakenly attacks the kidneys, leading to inflammation and possibly to long-term organ damage, including kidney failure, if left untreated. Although most cases of lupus nephritis begin within five years of a lupus diagnosis, nearly one in five survey respondents who self-report having symptoms of kidney involvement have not been told by a doctor they have lupus nephritis.

In its early stages, the symptoms of lupus nephritis can go unnoticed. More than half of the respondents reported little or no knowledge of common symptoms of lupus nephritis (53%), when it is important to be screened (54%), and what tests are done to screen for lupus nephritis (57%). Symptoms of lupus nephritis include fluid retention leading to weight gain, swelling, an increase in urination (especially at night), blood in the urine, foamy appearance of the urine, and high blood pressure.

“These findings reveal a troubling reality—many people with lupus are living with kidney complications they don’t fully understand or even know they have,” said Louise Vetter, President & CEO of the Lupus Foundation of America. “Early diagnosis and access to appropriate treatment are essential for protecting kidney health and preventing long-term damage. We must act urgently to close these knowledge gaps and improve education of common symptoms and proper monitoring of the kidneys, in addition to improved care across the globe. As we recognize World Lupus Day on May 10, this is a moment to rally together, raise our voices, and fight for better outcomes for everyone living with lupus.”

Additional key findings include:

  • 74% of survey respondents who stated that their kidneys were not impacted by lupus reported one or more common symptoms of lupus nephritis, with an average of 1.5 symptoms.
  • 3 in 10 respondents with lupus nephritis reported little or no knowledge of the condition.
  • 59% of those with lupus nephritis reported having been hospitalized because of it.
  • More than one third (36%) of those reporting a lupus nephritis diagnosis have not had a kidney biopsy—the gold standard for diagnosing lupus nephritis.
  • Of those with lupus nephritis who have not had a kidney biopsy, 54% of them reported they were hesitant to have the procedure.

More than 3,260 people with lupus from 84 countries completed the 25-question survey administered in March 2025. The World Lupus Federation is releasing these survey results in the lead-up to World Lupus Day on May 10 to spotlight the urgent need for greater awareness, education, improved screening, and timely treatment of lupus and lupus nephritis.

The World Lupus Federation urges individuals, organizations, and healthcare providers worldwide to use this data to inform lupus education and awareness efforts, and to share facts about lupus, including from this survey, and raise awareness using the official World Lupus Day Toolkit.

For further survey details, view the topline visual summary and detailed survey results.

About the World Lupus Federation:

The World Lupus Federation (WLF) is a coalition of more than 200 lupus patient organizations, united to improve the quality of life for the approximately 5 million people around the world who are affected by lupus. Through coordinated efforts among its members, the Federation works to expand global initiatives that create greater awareness and understanding of lupus, provide education and services to people living with the disease and advocate on their behalf. The Lupus Foundation of America (LFA) co-founded the WLF with Lupus Europe in 2015 and the LFA currently serves as the Secretariat of the Federation.

MEDIA CONTACT

Mike Donnelly
World Lupus Federation
donnelly@lupus.org

Canadian Solar Releases New TOPCon 2.0 / 660 Wp N-Type Module with up to 24.4% Efficiency for Utility and C&I PV Systems

KITCHENER, ON, May 6, 2025 /PRNewswire/ — Canadian Solar Inc. (the “Company” or “Canadian Solar”) (NASDAQ: CSIQ) today announced the launch of its new N-type high power TOPBiHiKu CS6.2 module series for both Utility and Commercial & Industrial Systems. Based on the latest TOPCon cell technology, the module delivers a maximum power output up to 660 Wp and a conversion efficiency of up to 24.4%. Canadian Solar is beginning with its global deliveries in August 2025.

The TOPCon 2.0 module series integrates cutting-edge innovations to maximize energy yield and system value for maximum system performance and output with the following key technical innovations:

  • Fine line printing: Reduces finger width by over 30%, minimizing shading effect and improving incident light utilization by 1% (absolute).
  • Advanced firing process: Improves contact resistance and reduces carrier recombination in the contact area, increasing open-circuit voltage by 10 mV.
  • Rear polysilicon optimization: Minimizes parasitic absorption and reduces current loss, achieving bifaciality of up to 90%.
  • Next-gen passivation: Reduces emitter recombination losses by up to 20%, increasing cell efficiency by 0.1% (absolute) via open-circuit voltage optimization.
  • Ultra-precise SMBB design: Minimizes electrical resistance and associated power losses.

Canadian Solar’s new N-type high power module enhances project economics, offering up to 90% bifaciality, an optimized temperature coefficient (-0.28%/°C) which enables up to 2% lower balance of system costs, and up to 5% reduction in LCOE compared to today’s standard TOPCon PV modules.

Thomas Koerner, Corporate Senior Vice President of Canadian Solar, remarked, “We are pleased to announce our new N-type high power module. The CS6.2 module-series represents a significant leap forward in solar technology, delivering highest module efficiency, significantly lower LCOE, and greater sustainability for utility and commercial and industrial PV projects. With this launch, we reaffirm our commitment to innovation and customer centric developments as a leader of the global energy transition.”

The TOPCon 2.0 module series will be showcased at Intersolar Europe from May 7 to 9, in Munich, Germany. Visit Canadian Solar booth A2.380 to learn more.

About Canadian Solar Inc.

Canadian Solar is one of the world’s largest solar technology and renewable energy companies. Founded in 2001 and headquartered in Kitchener, Ontario, the Company is a leading manufacturer of solar photovoltaic modules; provider of solar energy and battery energy storage solutions; and developer, owner, and operator of utility-scale solar power and battery energy storage projects. Over the past 24 years, Canadian Solar has successfully delivered nearly 150 GW of premium-quality, solar photovoltaic modules to customers across the world. Through its subsidiary e-STORAGE, Canadian Solar has shipped over 10 GWh of battery energy storage solutions to global markets as of December 31, 2024, boasting a US$3.2 billion contracted backlog as of December 31, 2024. Since entering the project development business in 2010, Canadian Solar has developed, built, and connected approximately 11.5 GWp of solar power projects and 4.5 GWh of battery energy storage projects globally. Its geographically diversified project development pipeline includes 25 GWp of solar and 75 GWh of battery energy storage capacity in various stages of development. Canadian Solar is one of the most bankable companies in the solar and renewable energy industry, having been publicly listed on the NASDAQ since 2006. For additional information about the Company, follow Canadian Solar on LinkedIn or visit www.canadiansolar.com.

Safe Harbor/Forward-Looking Statements 

Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially. These statements are made under the “Safe Harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by such terms as “believes,” “expects,” “anticipates,” “intends,” “estimates,” the negative of these terms, or other comparable terminology. Factors that could cause actual results to differ include general business, regulatory and economic conditions and the state of the solar power and battery energy storage market and industry; geopolitical tensions and conflicts, including impasses, sanctions and export controls; volatility, uncertainty, delays and disruptions related to global pandemics; supply chain disruptions; governmental support for the deployment of solar power and battery energy storage; future available supplies of silicon, solar wafers and lithium cells; demand for end-use products by consumers and inventory levels of such products in the supply chain; changes in demand from significant customers; changes in demand from major markets such as China, the U.S., Europe, Brazil and Japan; changes in effective tax rates; changes in customer order patterns; changes in product mix; changes in corporate responsibility, especially environmental, social and governance (“ESG”) requirements; capacity utilization; level of competition; pricing pressure and declines in or failure to timely adjust average selling prices; delays in new product introduction; delays in utility-scale project approval process; delays in utility-scale project construction; delays in the completion of project sales; the pipeline of projects and timelines related to them; the ability of the parties to optimize value of that pipeline; continued success in technological innovations and delivery of products with the features that customers demand; shortage in supply of materials or capacity requirements; availability of financing; exchange and inflation rate fluctuations; litigation and other risks as described in the Company’s filings with the Securities and Exchange Commission, including its annual report on Form 20-F filed on April 30, 2025. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, it cannot guarantee future results, level of activity, performance, or achievements. Investors should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date, unless otherwise stated, and Canadian Solar undertakes no duty to update such information, except as required under applicable law.

CANADIAN SOLAR INC. INVESTOR RELATIONS CONTACT
Wina Huang
Investor Relations Canadian Solar Inc.
investor@canadiansolar.com